(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are LATECOERE, INTEROIL EXPL PROD, and EXMAR.

Financial Asset	Price	Change	Updated (EST)
LATECOERE (LAT.PA)	0.40	3261.34%	2023-11-02 13:05:46
INTEROIL EXPL PROD (IOX.OL)	0.65	29.74%	2023-11-02 12:41:19
EXMAR (EXM.BR)	7.60	29.25%	2023-11-02 12:06:09
FERMENTALG (FALG.PA)	0.29	26.09%	2023-11-02 13:03:36
LHYFE (LHYFE.PA)	3.85	21.84%	2023-11-02 13:05:56
NORTHERN DRILLING (NODL.OL)	2.01	18.24%	2023-11-02 12:42:50
ARCTICZYMES TECHNO (AZT.OL)	32.60	17.9%	2023-11-02 12:24:31
SCATEC (SCATC.OL)	64.30	15.75%	2023-11-02 12:44:41
AVENIR TELECOM (AVT.PA)	0.17	13.2%	2023-11-02 12:48:44
DEEZER (DEEZR.PA)	2.70	10.66%	2023-11-02 13:02:15

The three biggest losers today are BENEVOLENTAI, CABKA EUR 12W, and CABKA EUR 13W.

Financial Asset	Price	Change	Updated (EST)
BENEVOLENTAI (BAI.AS)	0.76	-20%	2023-11-02 12:00:55
CABKA EUR 12W (DSCW2.AS)	0.05	-16.67%	2023-11-02 12:01:12
CABKA EUR 13W (DSCW3.AS)	0.05	-16.67%	2023-11-02 12:01:14
CNOVA (CNV.PA)	1.20	-14.29%	2023-11-02 13:01:22
ODFJELL SER. B (ODFB.OL)	106.00	-8.62%	2023-11-02 12:43:09
METABOLIC EXPLORER (METEX.PA)	0.69	-8.16%	2023-11-02 13:20:22
ODFJELL SER. A (ODF.OL)	111.50	-6.69%	2023-11-02 12:43:07
PCI BIOTECH HOLD (PCIB.OL)	2.11	-6.44%	2023-11-02 12:43:32
SCBSM (CBSM.PA)	8.45	-6.11%	2023-11-02 13:22:20
ARRIBATEC GROUP (ARR.OL)	4.36	-5.82%	2023-11-02 12:24:35

Winners today

1. LATECOERE (LAT.PA)

3261.34% Price Change

Latécoère S.A. designs, manufactures, assembles, and installs aerostructures and interconnection systems in Europe, the United States, Africa, Asia, and internationally. The company operates through Aerostructures and Interconnection systems segments. It also supplies doors, fuselage, wings, empennage, and connecting rods, as well as manufactures wing sub-assemblies and fuselage components, such as sections, tail cones, front fairings, and watertight bulkheads. In addition, the company offers interconnection systems components comprising of avionics racks, test benches, EWIS and space harnesses; cameras, screens, data transmission solutions; and other electronics. The company was founded in 1917 and is headquartered in Toulouse, France. Latécoère S.A. is a subsidiary of SCP SKN HOLDING I SAS.

CAC 40 ended the session with LATECOERE rising 3261.34% to €0.40 on Thursday, after two consecutive sessions in a row of losses. CAC 40 rose 1.85% to €7,060.69, after three sequential sessions in a row of gains, on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, LATECOERE has a trailing twelve months EPS of €-8.26.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -311.52%.

More news about LATECOERE.

2. INTEROIL EXPL PROD (IOX.OL)

29.74% Price Change

Interoil Exploration and Production ASA, together with its subsidiaries, operates as an upstream oil exploration and production company. It engages in the acquisition, exploration, development, and operation of oil and natural gas properties. The company's portfolio includes two producing concessions and two exploration concessions in Colombia; and one exploration and seven production concessions in Argentina. Interoil Exploration and Production ASA was incorporated in 2005 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with INTEROIL EXPL PROD jumping 29.74% to €0.65 on Thursday while Oslo Børs Benchmark Index_GI jumped 0.83% to €1,291.81.

Earnings Per Share

As for profitability, INTEROIL EXPL PROD has a trailing twelve months EPS of kr-0.32.

Yearly Top and Bottom Value

INTEROIL EXPL PROD’s stock is valued at kr0.65 at 21:40 EST, way under its 52-week high of kr1.29 and way higher than its 52-week low of kr0.51.

Revenue Growth

Year-on-year quarterly revenue growth declined by 41.7%, now sitting on 14.09M for the twelve trailing months.

Earnings Before Interest, Taxes, Depreciation, and Amortization

INTEROIL EXPL PROD’s EBITDA is 13.39.

More news about INTEROIL EXPL PROD.

3. EXMAR (EXM.BR)

29.25% Price Change

Exmar NV provides shipping and energy supply chain solutions worldwide. It operates through three segments: Shipping, Infrastructure, and Supporting Services. The company transports liquefied gas products, such as liquid petroleum gas, butane, propane, anhydrous ammonia, and petrochemical gases. It also engages in ownership and leasing of offshore assets; asset construction; and provision of engineering services related to marine vessels, ships, and offshore units to the marine oil and gas industry. In addition, the company builds, owns, and operates LNG infrastructure comprising floating liquefaction of gas fields, and floating storage and regasification units, as well as provides ship-to-ship transfer services. Further, it provides ship management services, consultancy and engineering, and travel agency services; and manufactures ropes for marine and offshore applications. Additionally, the company designs, builds, installs, and operates floating production, storage, and offloading units; and operates, installs, and maintains contractor, mining companies, drilling contractors, and accommodation barges. Exmar NV was founded in 1829 and is headquartered in Antwerp, Belgium. As of September 15, 2023, Exmar NV operates as a subsidiary of Saverex NV.

BEL 20 ended the session with EXMAR jumping 29.25% to €7.60 on Thursday while BEL 20 jumped 2.31% to €3,455.08.

Earnings Per Share

As for profitability, EXMAR has a trailing twelve months EPS of €5.48.

PE Ratio

EXMAR has a trailing twelve months price to earnings ratio of 1.39. Meaning, the purchaser of the share is investing €1.39 for every euro of annual earnings.

Volatility

EXMAR’s last week, last month’s, and last quarter’s current intraday variation average was 0.54%, 0.12%, and 0.89%.

EXMAR’s highest amplitude of average volatility was 0.54% (last week), 0.40% (last month), and 0.89% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EXMAR’s stock is considered to be oversold (<=20).

Volume

Today’s last reported volume for EXMAR is 228166 which is 308.23% above its average volume of 55891.

More news about EXMAR.

4. FERMENTALG (FALG.PA)

26.09% Price Change

Fermentalg SA develops, produces, and sells active ingredients extracted from microalgae for the food, health, nutrition, and environment sectors in France and internationally. It offers DHA ORIGINS, a plant-based DHA oil; aquafeeds and pet foods; BLUE ORIGIN, a natural color; and environmental and clean air solutions that captures CO2 in industries. The company was incorporated in 2009 and is headquartered in Libourne, France.

CAC 40 ended the session with FERMENTALG jumping 26.09% to €0.29 on Thursday while CAC 40 rose 1.85% to €7,060.69.

Earnings Per Share

As for profitability, FERMENTALG has a trailing twelve months EPS of €-0.24.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.52%.

Moving Average

FERMENTALG’s value is way below its 50-day moving average of €0.50 and way under its 200-day moving average of €0.90.

More news about FERMENTALG.

5. LHYFE (LHYFE.PA)

21.84% Price Change

Lhyfe SA, a renewable energy company, designs, installs, and operates green hydrogen production units in France. The company operates 93 projects. It serves local authorities, industries, transport and logistics, and fuel distribution. The company was founded in 2017 and is headquartered in Nantes, France.

CAC 40 ended the session with LHYFE jumping 21.84% to €3.85 on Thursday while CAC 40 jumped 1.85% to €7,060.69.

Earnings Per Share

As for profitability, LHYFE has a trailing twelve months EPS of €-0.47.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.12%.

Yearly Top and Bottom Value

LHYFE’s stock is valued at €3.85 at 21:40 EST, way below its 52-week high of €9.40 and way above its 52-week low of €2.83.

More news about LHYFE.

6. NORTHERN DRILLING (NODL.OL)

18.24% Price Change

Northern Drilling Ltd. operates as an offshore drilling contractor to the oil and gas industry. The company primarily engages in acquiring and operating offshore drilling assets, as well as involved in drilling in ultra-deep water environments. Northern Drilling Ltd. was incorporated in 2017 and is based in Hamilton, Bermuda.

Oslo Børs Benchmark Index_GI ended the session with NORTHERN DRILLING rising 18.24% to €2.01 on Thursday while Oslo Børs Benchmark Index_GI rose 0.83% to €1,291.81.

Earnings Per Share

As for profitability, NORTHERN DRILLING has a trailing twelve months EPS of kr-6.24.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.22%.

Moving Average

NORTHERN DRILLING’s value is way below its 50-day moving average of kr15.84 and way under its 200-day moving average of kr25.75.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NORTHERN DRILLING’s stock is considered to be oversold (<=20).

Volume

Today’s last reported volume for NORTHERN DRILLING is 7492120 which is 963.38% above its average volume of 704555.

Yearly Top and Bottom Value

NORTHERN DRILLING’s stock is valued at kr2.01 at 21:40 EST, way under its 52-week high of kr34.90 and way higher than its 52-week low of kr0.31.

More news about NORTHERN DRILLING.

7. ARCTICZYMES TECHNO (AZT.OL)

17.9% Price Change

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, In vitro diagnostics, and biomanufacturing. It offers salt active nuclease for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays; double-strand specific DNases and derived kits for the removal of double stranded DNA; polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining nucleic acids. It operates in Norway, Germany, Lithuania, Italy, other countries in Europe, the United States, and internationally. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was founded in 1990 and is headquartered in Tromsø, Norway.

Oslo Børs Benchmark Index_GI ended the session with ARCTICZYMES TECHNO jumping 17.9% to €32.60 on Thursday while Oslo Børs Benchmark Index_GI jumped 0.83% to €1,291.81.

Earnings Per Share

As for profitability, ARCTICZYMES TECHNO has a trailing twelve months EPS of kr0.27.

PE Ratio

ARCTICZYMES TECHNO has a trailing twelve months price to earnings ratio of 120.74. Meaning, the purchaser of the share is investing kr120.74 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.15%.

Volatility

ARCTICZYMES TECHNO’s last week, last month’s, and last quarter’s current intraday variation average was a positive 2.01%, a negative 0.35%, and a positive 2.28%.

ARCTICZYMES TECHNO’s highest amplitude of average volatility was 4.63% (last week), 2.49% (last month), and 2.28% (last quarter).

Volume

Today’s last reported volume for ARCTICZYMES TECHNO is 81080 which is 76.49% above its average volume of 45940.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 100% and 650%, respectively.

Moving Average

ARCTICZYMES TECHNO’s worth is way below its 50-day moving average of kr37.84 and way under its 200-day moving average of kr46.41.

More news about ARCTICZYMES TECHNO.

8. SCATEC (SCATC.OL)

15.75% Price Change

Scatec ASA, together with its subsidiaries, provides renewable energy solutions worldwide. The company operates through Power Production; Services; and Development & Construction segments. It develops, builds, owns, and operates solar, wind, and hydro power plants and storage solutions. The company is also involved in the engineering, procurement, construction, operation, maintenance, and asset management of power plants. It has a total of 4.6 GW in operation and under construction. The company was formerly known as Scatec Solar ASA and changed its name to Scatec ASA in November 2020. Scatec ASA was incorporated in 2007 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with SCATEC rising 15.75% to €64.30 on Thursday while Oslo Børs Benchmark Index_GI rose 0.83% to €1,291.81.

Earnings Per Share

As for profitability, SCATEC has a trailing twelve months EPS of kr0.21.

PE Ratio

SCATEC has a trailing twelve months price to earnings ratio of 306.19. Meaning, the purchaser of the share is investing kr306.19 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.17%.

Sales Growth

SCATEC’s sales growth is 42.4% for the present quarter and 42.7% for the next.

Moving Average

SCATEC’s value is above its 50-day moving average of kr64.04 and way under its 200-day moving average of kr71.89.

Volatility

SCATEC’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.87%, a negative 0.42%, and a positive 1.99%.

SCATEC’s highest amplitude of average volatility was 1.09% (last week), 2.78% (last month), and 1.99% (last quarter).

More news about SCATEC.

9. AVENIR TELECOM (AVT.PA)

13.2% Price Change

Avenir Telecom S.A. designs and distributes mobile phones and mobility accessories in Europe, the Middle East, Africa, Asia, Oceania, and the Americas. The company also provides chargers, cables, memory cards, and screen protectors. It offers its products under the Energizer brand. The company was incorporated in 1989 and is headquartered in Marseille, France.

CAC 40 ended the session with AVENIR TELECOM rising 13.2% to €0.17 on Thursday while CAC 40 rose 1.85% to €7,060.69.

Earnings Per Share

As for profitability, AVENIR TELECOM has a trailing twelve months EPS of €-0.18.

Volume

Today’s last reported volume for AVENIR TELECOM is 777126 which is 101.89% above its average volume of 384920.

More news about AVENIR TELECOM.

10. DEEZER (DEEZR.PA)

10.66% Price Change

Deezer S.A. provides music streaming services worldwide. The company streams songs, audio books, podcast, and radio channels. It offers its music steaming services through website, Deezer.com and other wireless audio systems; and operates in approximately 180 countries. The company is based in Paris, France.

CAC 40 ended the session with DEEZER jumping 10.66% to €2.70 on Thursday while CAC 40 rose 1.85% to €7,060.69.

Earnings Per Share

As for profitability, DEEZER has a trailing twelve months EPS of €-1.35.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, DEEZER’s stock is considered to be overbought (>=80).

Moving Average

DEEZER’s worth is way higher than its 50-day moving average of €2.36 and way above its 200-day moving average of €2.19.

More news about DEEZER.

Losers Today

1. BENEVOLENTAI (BAI.AS)

-20% Price Change

BenevolentAI S.A. operates as a clinical-stage AI-enabled drug discovery and development company. Its BenevolentAI platform powers in-house drug pipeline of drug programs. The company's therapeutic areas, include atopic dermatitis, ulcerative colitis, amyotrophic lateral sclerosis, glioblastoma multiforme, inflammatory bowel disease, antiviral, oncology, parkinson's disease, nonalcoholic steatohepatitis, fibrosis, inflammation, chronic kidney disease, and idiopathic pulmonary fibrosis. It has a collaboration with AstraZeneca to enhance understanding of complex disease biology and identify new targets. The company was founded in 2013 and is headquartered in London, United Kingdom.

AEX-Index ended the session with BENEVOLENTAI sliding 20% to €0.76 on Thursday, after five consecutive sessions in a row of losses. AEX-Index jumped 1.91% to €736.03, after two successive sessions in a row of gains, on what was an all-around up trend exchanging session today.

Earnings Per Share

As for profitability, BENEVOLENTAI has a trailing twelve months EPS of €-0.47.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -40.97%.

Volume

Today’s last reported volume for BENEVOLENTAI is 500 which is 88.41% below its average volume of 4316.

Moving Average

BENEVOLENTAI’s value is way under its 50-day moving average of €0.98 and way under its 200-day moving average of €1.92.

More news about BENEVOLENTAI.

2. CABKA EUR 12W (DSCW2.AS)

-16.67% Price Change

AEX-Index ended the session with CABKA EUR 12W dropping 16.67% to €0.05 on Thursday while AEX-Index rose 1.91% to €736.03.

Yearly Top and Bottom Value

CABKA EUR 12W’s stock is valued at €0.05 at 21:40 EST, way below its 52-week low of €0.06.

More news about CABKA EUR 12W.

3. CABKA EUR 13W (DSCW3.AS)

-16.67% Price Change

AEX-Index ended the session with CABKA EUR 13W falling 16.67% to €0.05 on Thursday while AEX-Index rose 1.91% to €736.03.

Yearly Top and Bottom Value

CABKA EUR 13W’s stock is valued at €0.05 at 21:40 EST, way under its 52-week low of €0.06.

More news about CABKA EUR 13W.

4. CNOVA (CNV.PA)

-14.29% Price Change

Cnova N.V. operates as an e-commerce company in France and Western Europe. The company offers home appliances, consumer electronics, computers, home furnishings, and leisure and personal goods through its cdiscount.com website. It also operates Cdiscount Voyages, a travel platform; Cdiscount Mobile for cell phone plans; Cdiscount Advertising, a digital marketing solution; Octopia for turnkey marketplace solutions to retailers and e-merchants; and C-Logistics for transportation and logistics services. The company was founded in 1998 and is headquartered in Amsterdam, the Netherlands. Cnova N.V. is a subsidiary of Casino, Guichard-Perrachon S.A.

CAC 40 ended the session with CNOVA falling 14.29% to €1.20 on Thursday while CAC 40 rose 1.85% to €7,060.69.

Earnings Per Share

As for profitability, CNOVA has a trailing twelve months EPS of €-0.35.

Volatility

CNOVA’s last week, last month’s, and last quarter’s current intraday variation average was a negative 10.76%, a negative 3.04%, and a positive 4.58%.

CNOVA’s highest amplitude of average volatility was 10.76% (last week), 5.88% (last month), and 4.58% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth declined by 29.9%, now sitting on 1.44B for the twelve trailing months.

More news about CNOVA.

5. ODFJELL SER. B (ODFB.OL)

-8.62% Price Change

Odfjell SE engages in the transportation and storage of bulk liquid chemicals, acids, edible oils, and other special products. The company operates Chemical Tankers and Tank Terminals segments. It owns and operates chemical tankers that offers global and regional transportation; and tank terminals, which provides storage of various chemical and petroleum products. As of December 31, 2022, it operated a chemical tanker fleet of 69 vessels, including 46 owned, 6 bareboat chartered, 14 time chartered vessels, and 3 pool vessels. The company's terminal network comprises of 450 tanks with 1.2 million cubic meters of storage capacity. It operates in Norway, the Netherlands, rest of Europe, North America, South America, the Middle East, Asia, Australasia, and Africa. Odfjell SE was founded in 1914 and is headquartered in Bergen, Norway.

Oslo Børs Benchmark Index_GI ended the session with ODFJELL SER. B dropping 8.62% to €106.00 on Thursday while Oslo Børs Benchmark Index_GI rose 0.83% to €1,291.81.

Earnings Per Share

As for profitability, ODFJELL SER. B has a trailing twelve months EPS of kr27.98.

PE Ratio

ODFJELL SER. B has a trailing twelve months price to earnings ratio of 3.79. Meaning, the purchaser of the share is investing kr3.79 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.82%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 13.8%, now sitting on 1.27B for the twelve trailing months.

Moving Average

ODFJELL SER. B’s value is way higher than its 50-day moving average of kr94.93 and way above its 200-day moving average of kr92.22.

Volume

Today’s last reported volume for ODFJELL SER. B is 31674 which is 338.82% above its average volume of 7218.

More news about ODFJELL SER. B.

6. METABOLIC EXPLORER (METEX.PA)

-8.16% Price Change

METabolic EXplorer S.A., a biological chemistry company, engages in the development and industrialization of industrial fermentation processes as alternatives to petrochemical processes worldwide. The company also offers propanediol, butyric acid, butyric acid, glycolic acid, amino acid, and L-Valine. Its products are used in the formulation of cosmetics, textiles, polymer, animal nutrition, and health products or as intermediates for the synthesis of biomaterials. The company was incorporated in 1999 and is based in Saint-Beauzire, France.

CAC 40 ended the session with METABOLIC EXPLORER sliding 8.16% to €0.69 on Thursday, after five sequential sessions in a row of gains. CAC 40 rose 1.85% to €7,060.69, after three sequential sessions in a row of gains, on what was an all-around positive trend trading session today.

Earnings Per Share

As for profitability, METABOLIC EXPLORER has a trailing twelve months EPS of €-0.98.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -42.82%.

Moving Average

METABOLIC EXPLORER’s value is way higher than its 50-day moving average of €0.53 and way below its 200-day moving average of €0.96.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend yield is 0.04%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, METABOLIC EXPLORER’s stock is considered to be oversold (<=20).

More news about METABOLIC EXPLORER.

7. ODFJELL SER. A (ODF.OL)

-6.69% Price Change

Odfjell SE engages in the transportation and storage of bulk liquid chemicals, acids, edible oils, and other special products. The company operates Chemical Tankers and Tank Terminals segments. It owns and operates chemical tankers that offers global and regional transportation; and tank terminals, which provides storage of various chemical and petroleum products. As of December 31, 2022, it operated a chemical tanker fleet of 69 vessels, including 46 owned, 6 bareboat chartered, 14 time chartered vessels, and 3 pool vessels. The company's terminal network comprises of 450 tanks with 1.2 million cubic meters of storage capacity. It operates in Norway, the Netherlands, rest of Europe, North America, South America, the Middle East, Asia, Australasia, and Africa. Odfjell SE was founded in 1914 and is headquartered in Bergen, Norway.

Oslo Børs Benchmark Index_GI ended the session with ODFJELL SER. A falling 6.69% to €111.50 on Thursday while Oslo Børs Benchmark Index_GI rose 0.83% to €1,291.81.

Earnings Per Share

As for profitability, ODFJELL SER. A has a trailing twelve months EPS of kr27.99.

PE Ratio

ODFJELL SER. A has a trailing twelve months price to earnings ratio of 3.98. Meaning, the purchaser of the share is investing kr3.98 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.82%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ODFJELL SER. A’s stock is considered to be oversold (<=20).

Earnings Before Interest, Taxes, Depreciation, and Amortization

ODFJELL SER. A’s EBITDA is 159.53.

Yearly Top and Bottom Value

ODFJELL SER. A’s stock is valued at kr111.50 at 21:40 EST, below its 52-week high of kr121.00 and way above its 52-week low of kr67.60.

More news about ODFJELL SER. A.

8. PCI BIOTECH HOLD (PCIB.OL)

-6.44% Price Change

PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in pre-clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Olix Pharmaceuticals, Aposense, IMV Immunovaccine, MDimune, eTheRNA, and Immunicum. PCI Biotech Holding ASA was incorporated in 2007 and is based in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with PCI BIOTECH HOLD falling 6.44% to €2.11 on Thursday, after two consecutive sessions in a row of losses. Oslo Børs Benchmark Index_GI jumped 0.83% to €1,291.81, after four sequential sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, PCI BIOTECH HOLD has a trailing twelve months EPS of kr-0.79.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -47.54%.

Yearly Top and Bottom Value

PCI BIOTECH HOLD’s stock is valued at kr2.11 at 21:40 EST, way below its 52-week high of kr5.93 and way above its 52-week low of kr1.20.

Earnings Before Interest, Taxes, Depreciation, and Amortization

PCI BIOTECH HOLD’s EBITDA is -4.54.

Volume

Today’s last reported volume for PCI BIOTECH HOLD is 304245 which is 40.26% below its average volume of 509357.

More news about PCI BIOTECH HOLD.

9. SCBSM (CBSM.PA)

-6.11% Price Change

Societe Centrale des Bois et Scieries de la Manche engages in the ownership, management, and lease of real estate properties in France. It leases offices, business properties, mixed activity locations, and residences. The company is based in Paris, France.

CAC 40 ended the session with SCBSM sliding 6.11% to €8.45 on Thursday, following the last session’s upward trend. CAC 40 rose 1.85% to €7,060.69, after three consecutive sessions in a row of gains, on what was an all-around up trend exchanging session today.

Earnings Per Share

As for profitability, SCBSM has a trailing twelve months EPS of €2.49.

PE Ratio

SCBSM has a trailing twelve months price to earnings ratio of 3.39. Meaning, the purchaser of the share is investing €3.39 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.29%.

Volatility

SCBSM’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.96%, a negative 0.71%, and a positive 1.75%.

SCBSM’s highest amplitude of average volatility was 2.71% (last week), 2.81% (last month), and 1.75% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SCBSM’s stock is considered to be oversold (<=20).

Moving Average

SCBSM’s worth is way below its 50-day moving average of €9.42 and way under its 200-day moving average of €9.67.

More news about SCBSM.

10. ARRIBATEC GROUP (ARR.OL)

-5.82% Price Change

Arribatec Group ASA, a software and consulting company, provides digital business solutions in Norway, Europe, the Americas, and internationally. The company offers solutions for businesses, including ERP systems, integrations, consulting, health checks, develops, HR and payroll, financial and project planning, bank solutions, and travel and expenses. Its solutions include QualiWare, a management system that structures and visualizes processes, activities, regulations, and requirements; Unit4 solutions; RamBase, an ERP business solution that gives control over the value chain; Power BI solutions; Hypergene, a business management tool; Adra Suite that integrates with other financial systems; Microsoft 365; CatalystOne; and Pagero that ensures compliance with legal and electronic billing requirements. The company was incorporated in 1998 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ARRIBATEC GROUP falling 5.82% to €4.36 on Thursday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI jumped 0.83% to €1,291.81, after four consecutive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, ARRIBATEC GROUP has a trailing twelve months EPS of kr-1.38.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.94%.

Volume

Today’s last reported volume for ARRIBATEC GROUP is 281263 which is 228.32% above its average volume of 85667.

Moving Average

ARRIBATEC GROUP’s worth is way under its 50-day moving average of kr5.92 and way above its 200-day moving average of kr3.71.

Yearly Top and Bottom Value

ARRIBATEC GROUP’s stock is valued at kr4.36 at 21:40 EST, way under its 52-week high of kr6.81 and way above its 52-week low of kr0.30.

Revenue Growth

Year-on-year quarterly revenue growth grew by 23.2%, now sitting on 557M for the twelve trailing months.

More news about ARRIBATEC GROUP.

Stay up to date with our winners and losers daily report